PHASE I STUDY OF RADIATION THERAPY (RT) FOLLOWED BY INTRATHECAL (IT) TRASTUZUMAB/ PERTUZUMAB IN THE MANAGEMENT OF HER2+ BREAST LEPTOMENINGEAL DISEASE (LMD)

Authors
Category Primary study
JournalNeuro-Oncology
Year 2023
This article has no abstract
Epistemonikos ID: d3135aa49d5b54cb6099c3dc3dec2bc97fa95cea
First added on: Feb 17, 2025